To evaluate whether YY1 was required for cisplatin resistance in HNSCC cells, we used Tet-on inducible shRNA or lentiviral shRNA to knockdown YY1 in CAL27 cells. The gene discussed is YY1; the disease is head and neck squamous cell carcinoma.